Nivalis Therapeutics to Present at the Jefferies 2016 Healthcare Conference
BOULDER, Colo., June 01, 2016 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis (“CF”), today announced that Chief Executive Officer, Jon Congleton will present a corporate overview at the Jefferies 2016 Healthcare Conference.
Details of the presentations are as follows:
Jefferies 2016 Healthcare Conference
Date: Tuesday, June 7th
Location: Grand Hyatt, New York
Presentation Time: 9:00 AM EDT
Individuals may access a live webcast of the conference presentations on the Nivalis website at www.nivalis.com under "IR Calendar" in the "News / Events" section. A replay of the webcast will be available on this site for 90 days following the live event.
About Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. (http://www.nivalis.com) is a clinical-stage pharmaceutical company committed to the discovery, development and commercialization of therapeutics for people with CF. In addition to developing innovative solutions intended to extend and improve the lives of people with CF, Nivalis plans to utilize its proprietary S-nitrosoglutathione reductase (GSNOR) inhibitor portfolio to develop therapeutics for other diseases.
Contacts: Investor Relations John Graziano 1-646-378-2942 firstname.lastname@example.org Media Relations Lindsay Rocco 1-862-596-1304 email@example.com